We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · June 13, 2020

Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction

JAMA Cardiology

 

Additional Info

JAMA Cardiology
Efficacy of Evolocumab on Cardiovascular Outcomes in Patients With Recent Myocardial Infarction: A Prespecified Secondary Analysis From the FOURIER Trial
JAMA Cardiol 2020 May 20;[EPub Ahead of Print], B Gencer, F Mach, SA Murphy, GM De Ferrari, K Huber, BS Lewis, J Ferreira, CE Kurtz, H Wang, N Honarpour, AC Keech, PS Sever, TR Pedersen, MS Sabatine, RP Giugliano

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading